Clinical Trials

Showing trials with last updates posted in 2024.

NCT05807126 | WITHDRAWN | PHASE1
0 participants

Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations

Study Type:
INTERVENTIONAL
Last Updated:
2024-05-02
Start Date:
2024-03-05
Completion:
2026-12-06
Conditions
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Castration-Resistant Prostate Carcinoma
  • Stage IVB Prostate Cancer AJCC v8
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page